Yalçın Seyhun: Influence Statistics

Yalçın Seyhun

Yalçın Seyhun

Istanbul University Department of Medical Biology Istanbul Faculty of Medicine Istanbul Turkey | Department of Medical Biology, Istanbul University, Istanbul, Turkey | ...

Yalçın Seyhun: Expert Impact

Concepts for which Yalçın Seyhun has direct influence: Severe sepsis , Neonatal sepsis , Graft rejection , Calcineurin inhibitors , Pct crp , Crp pct , Renal transplant .

Yalçın Seyhun: KOL impact

Concepts related to the work of other authors for which for which Yalçın Seyhun has influence: Neonatal sepsis , Septic shock , Acute rejection , Renal transplantation , Intravenous immunoglobulin , Reactive protein , Adjunctive therapy .

KOL Resume for Yalçın Seyhun

Year
2015

Istanbul University Department of Medical Biology Istanbul Faculty of Medicine Istanbul Turkey

2012

Department of Medical Biology, Istanbul University, Istanbul, Turkey

2011

Department of Medical Biology, Istanbul Medical Faculty, Istanbul University, Istanbul

2009

Department of Medical Biology, Istanbul University, Istanbul Medical Faculty, Istanbul, Turkey

2004

University of Istanbul, Cerrahpasa Faculty of Medicine, Department of Microbiology and Clinical Microbiology, Istanbul, Turkey 2,3University of Istanbul, Istanbul Medical Faculty, Medical Biology Department2 and Department of Microbiology and Clinical Microbiology3, Istanbul, Turkey 4Metropolitan Florence Nightingale Hospital, Gastroenterology Department, Istanbul, Turkey.

2002

Registrar, Medical Biology Department, Medical FacultyIstanbul University, Turkey

2000

Istanbul School of Dentistry, Istanbul, and, Division of Nephrology, Department of Internal Medicine, and, Department of Medical Biology, Istanbul School of Medicine, Istanbul, Turkey

Prominent publications by Yalçın Seyhun

KOL-Index: 7764 . IntroductionIn this prospective, randomized controlled study, we aimed to evaluate the effect of IgM-enriched immunoglobulin treatment on progression of organ failure and septic shock in patients with severe sepsis.Materials and methodsForty-two patients with severe sepsis were enrolled in the study. Patients in the study group (n = 21) received an intravenous immunoglobulin preparation ...
Known for Severe Sepsis | Organ Failure | Enriched Immunoglobulin | Patients Control
KOL-Index: 5423 . After allogeneic hematopoietic stem cell transplantation, risk factors for cytomegalovirus (CMV) reactivation include pretransplantation donor and recipient CMV serologic status and posttransplantation development of acute graft-vs-host disease (aGvHD). Human leukocyte antigen (HLA) allele type is an additional factor in CMV infection. The present study included 108 patients who received ...
Known for Cmv Infection | Stem Cell | Hla Antigens | Allogeneic Hematopoietic
KOL-Index: 5405 . The aims of this study were to determine the levels of procalcitonin (PCT) and C-reactive protein (CRP) in Helicobacter pylori-positive (HP+) patients diagnosed with duodenal and gastric ulcer and to evaluate the correlation of PCT and CRP levels with other invasive and non-invasive diagnostic methods for determination of H. pylori eradication in post-treatment follow-up. Thirty-five HP+ ...
Known for Helicobacter Pylori | Reactive Protein | Crp Levels | Dyspepsia Female
KOL-Index: 4446 . BACKGROUND: This study was designed to determine whether human leukocyte antigen (HLA) and major histocompatibility complex class I chain-related A (MICA) antibody (Ab) production during the first 6 months posttransplantation correlated with long-term graft survival and rejection rate. The study group included 147 first transplantations from either living related (LRDs) or deceased donors ...
Known for Kidney Transplantation | Hla Class | Major Histocompatibility | Human Leukocyte
KOL-Index: 4040 . INTRODUCTION: Certain cytokine gene polymorphisms (CGPs) have been shown to be associated with renal transplant rejection or graft outcomes. We sought to evaluate the relationship between gene polymorphisms in patients with acute rejection episodes (rejection group, RG, n = 19) versus those with stable graft function (nonrejection group, NRG, n = 71) in comparison with healthy control ...
Known for Gene Polymorphisms | Graft Rejection | Renal Transplant | Interleukin2 Il2
KOL-Index: 3960 . BACKGROUND: Certain cytokine gene polymorphisms (CGPs) have been shown to be associated with renal transplant rejection episodes or graft outcomes. We sought to evaluate the relationships between gene polymorphisms and acute rejection episodes (RG, n = 19) versus stable graft function (NRG, n = 71) in transplant recipients compared with healthy control subjects (HCG, n = 150). The ...
Known for Gene Polymorphisms | Graft Rejection | Renal Transplant | Single Nucleotide
KOL-Index: 3903 . Cytokines are essential for the control of the immune response as most of the immunosuppressive drugs target cytokine production or their action. The calcineurin inhibitors (CNIs) cyclosporine (CsA) and tacrolimus are immunosuppressive drugs widely used after renal transplantation to prevent allograft rejection. They are characterized by large interindividual variability in their ...
Known for Renal Transplant | Growth Factor | Immunosuppressive Agents | Genetic Association
KOL-Index: 3875 . The number of patients with end stage renal disease (ESRD) is increasing faster than the number of renal transplantations performed per year worldwide. Of the primary diseases leading to ESRD, diabetic nephropathy is the leading cause. The purpose of the present study is to investigate the association of HLA with the primary diseases leading to ESRD in Turkish patients. A total of 3230 ...
Known for Stage Renal Disease | Diabetic Nephropathy | Esrd Patients | Hla Antigens
KOL-Index: 3687 . Exposure to human leukocyte antigens (HLA) via blood transfusions, pregnancies, and previous transplantations can result in anti-HLA antibody production. The presence of anti-HLA antibodies in recipient sera before transplantation is an important risk factor. To demonstrate the anti-HLA antibody status of Turkish end-stage renal disease (ESRD) patients, 674 patients (mean age, 40.35 +/- ...
Known for Hla Antigens | Kidney Transplantation | Antibodies Frequent | Renal Dialysis
KOL-Index: 2271 . Gingival hyperplasia, a well-known side effect of ciclosporin A (CS-A), is much more prominent when CS-A is used in combination with calcium channel blockers, especially dihydropyridines. On the other hand, it is interesting to note that this complication is not observed in all patients using this drug combination. This study was conducted in order to investigate the relationship (if any) ...
Known for Renal Transplant Recipients | Gingival Hyperplasia | Calcium Channel | Cyclosporine Female
KOL-Index: 758 . OBJECTIVE: The objective of this study is to confirm whether there is relation between the human leucocyte antigen (HLA) locus and restenosis after percutaneous coronary intervention (PCI) holds in our patient population and whether it can be useful as a prognostic factor. METHODS: We examined the HLA phenotypes in 46 consecutive patients (39 men, 7 women, mean age of 57 ± 9 years) who had ...
Known for Coronary Artery | Stent Implantation | Pcr Ssp
KOL-Index: 392
Known for Autoimmune Hepatitis | Hla Drb1

Key People For Severe Sepsis

Top KOLs in the world
#1
JeanLouis MD JeanLouis
septic shock severe sepsis critically patients
#2
Derek C Angus
severe sepsis united states septic shock
#3
Mitchell M Levy
severe sepsis septic shock fluid responsiveness
#4
John C MD Marshall
septic shock critical illness severe sepsis
#5
Steven Michael Opal
severe sepsis septic shock antithrombin iii
#6
Konrad MD Reinhart
severe sepsis septic shock hydroxyethyl starch

Istanbul University Department of Medical Biology Istanbul Faculty of Medicine Istanbul Turkey | Department of Medical Biology, Istanbul University, Istanbul, Turkey | Department of Medical Biology and Genetics, Istanbul Bilim University, Istanbul, T